查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1720690

2025年急性護理症候群檢測全球市場報告

Acute Care Syndromic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

急性護理綜合症檢測市場預計在未來幾年將快速成長。到 2029 年，這一數字將成長至 75 億美元，複合年成長率為 12.9%。預測期內的成長可歸因於感染疾病病率的上升、對更快診斷解決方案的需求不斷增加、醫療服務的擴展、多重症候群面板的使用不斷增加以及老年人口的增加。預計在此期間的主要發展包括向就地檢驗的轉變、雲端基礎的平台的整合、多重面板的採用、人工智慧工具的開發以及綜合檢測自動化程度的提高。

預計感染疾病爆發的增加將推動急性護理症候群檢測市場的成長。感染疾病是由細菌、病毒、真菌和寄生蟲等有害微生物引起的，可透過人類與人類、動物和環境接觸傳播。人口成長、都市化、全球旅行、抗生素抗藥性、氣候變遷和其他治療因素導致這些疾病的發生率上升，增加了對有效診斷和治療方案的需求。急性護理綜合症檢測在透過多重分子診斷識別病原體和合併感染以確定針對性治療方面發揮關鍵作用。例如，2024年2月，英國衛生安全局報告稱，2024年第4週流感陽性率從前一周的14.0%上升至16.6%。流感樣疾病（ILI）就診率也有所增加，達到每 10 萬人 9.8 人（高於前一週的 7.5 人），流感住院人數從每 10 萬人 5.12 人增加到 7.63 人。因此，感染疾病率的上升刺激了急性護理綜合症檢測市場的擴張。

急性護理綜合症檢測市場的主要企業正在利用多重即時聚合酵素鏈鎖反應(PCR) 技術的進步來提高診斷準確性、快速病原體檢測、簡化實驗室工作流程並縮短週轉時間。多重即時PCR是一種先進的分子診斷方法，可在一次反應中同時檢測和量化多種病原體或基因標靶，以提高疾病診斷的效率和準確性。 2023年4月，荷蘭生技公司QIAGEN NV在日本推出了QIAstat-Dx症候群檢測解決方案。該系統具有 SARS-CoV-2 呼吸道檢測板，能夠從單一檢體中檢測出 20 多種病原體。它採用多重即時PCR技術，與傳統 PCR 檢測相比，能夠以最少的努力快速獲得結果。到 2022 年底，全球將安裝超過 3,500 套 QIAstat-Dx 系統，協助診斷呼吸道、胃腸道和腦膜炎相關疾病。該系統已覆蓋 100 多個國家，正在擴大全球範圍內獲得症候群檢測的機會。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 - 市場 - 宏觀經濟情境 宏觀經濟情境包括利率、通膨、地緣政治以及感染疾病和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球急性照護症候群檢視 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球急性護理綜合症檢測市場：成長率分析
  • 全球急性照護症候群檢測市場表現：規模與成長，2019-2024 年
  • 全球急性照護症候群檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球急性護理綜合症檢測總目標市場（TAM）

第6章市場區隔

  • 全球急性照護症候群檢測市場：依疾病類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 呼吸系統疾病
  • 消化系統疾病
  • 泌尿系統疾病
  • 熱帶疾病
  • 其他類型的疾病
  • 全球急性照護症候群檢測市場（按樣本類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 血
  • 尿
  • 生物體液
  • 凳子
  • 棉花棒
  • 其他樣本類型
  • 全球急性照護症候群檢測市場的目標、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 細菌
  • 病毒
  • 真菌
  • 寄生蟲
  • 全球急性照護症候群檢測市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 臨床和診斷實驗室
  • 研究和學術機構
  • 其他最終用戶
  • 全球急性照護症候群檢測市場按呼吸系統疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 流感
  • 呼吸道融合細胞病毒（RSV）
  • COVID-19
  • 結核
  • 其他呼吸系統疾病
  • 全球急性照護症候群檢測市場按胃腸道疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 困難梭狀芽孢桿菌傳染病
  • 諾羅病毒
  • 輪狀病毒
  • 沙門氏菌
  • 其他胃腸道疾病
  • 全球急性照護症候群檢測市場按泌尿系統疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 尿道感染（UTI）
  • 性行為感染感染（STI）
  • 陰道感染疾病
  • 其他泌尿生殖系統疾病
  • 全球急性照護症候群檢測市場按熱帶疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 瘧疾
  • 登革熱
  • 屈公病
  • 茲卡病毒
  • 其他熱帶疾病
  • 全球急性照護症候群檢測市場，按其他疾病類型細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 腦膜炎
  • 敗血症
  • 其他新興感染疾病

第7章 區域和國家分析

  • 全球急性照護症候群檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球急性護理綜合症檢測市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 急性護理綜合症檢測市場：競爭格局
  • 急性護理綜合症檢測市場：公司簡介
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Seegene Inc.
  • bioMerieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Werfen
  • DiaSorin SpA
  • Quidel Corporation
  • Luminex Corporation
  • Biocartis NV
  • Microbiologics Inc.
  • QuantuMDx Group Ltd.
  • Curetis GmbH by OpGen Inc.
  • Genetic Signatures Ltd.
  • Applied BioCode Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年急性照護症候群檢測市場：提供新機會的國家
  • 2029 年急性照護症候群檢測市場：細分市場將帶來新機會
  • 2029 年急性照護症候群檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33944

Acute care syndromic testing is a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. Primarily used in emergency and critical care settings, it enables quicker diagnosis of infectious diseases, leading to faster treatment decisions, improved patient outcomes, and reduced hospital stays.

The main disease types in the acute care syndromic testing market include respiratory diseases, gastrointestinal diseases, genitourinary diseases, tropical diseases, and others. Respiratory diseases affect the lungs, airways, and respiratory tract, causing symptoms such as coughing, shortness of breath, and fever. Various sample types used for testing include blood, urine, biofluids, stool, swabs, and more. The tests target bacteria, viruses, fungi, and parasites and are utilized in hospitals, clinical and diagnostic laboratories, research and academic institutions, and other healthcare settings.

The acute care syndromic testing market research report is one of a series of new reports from The Business Research Company that provides acute care syndromic testing market statistics, including the acute care syndromic testing industry's global market size, regional shares, competitors with a acute care syndromic testing market share, detailed acute care syndromic testing market segments, market trends and opportunities, and any further data you may need to thrive in the acute care syndromic testing industry. This acute care syndromic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The acute care syndromic testing market size has grown rapidly in recent years. It will grow from $4.08 billion in 2024 to $4.62 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth during the historic period can be attributed to increasing awareness of antimicrobial resistance, rising government funding for infectious disease research, greater investment in healthcare infrastructure, a growing focus on syndromic testing, the expansion of telemedicine, and the rising prevalence of infectious diseases.

The acute care syndromic testing market size is expected to see rapid growth in the next few years. It will grow to $7.50 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth during the forecast period can be attributed to the rising prevalence of infectious diseases, increasing demand for faster diagnostic solutions, the expansion of healthcare services, the growing use of multiplex syndromic panels, and a rising geriatric population. Key trends expected during this period include a shift toward point-of-care testing, the integration of cloud-based platforms, the adoption of multiplex panels, the development of AI-powered tools, and increased automation in syndromic testing.

The increasing prevalence of infectious diseases is expected to drive the growth of the acute care syndromic testing market. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can spread through human contact, animals, or the environment. Factors such as population growth, urbanization, global travel, antimicrobial resistance, and climate change are contributing to the rising incidence of these diseases, increasing the demand for effective diagnostic and treatment solutions. Acute care syndromic testing plays a crucial role in identifying pathogens and co-infections through multiplex molecular diagnostics, allowing for targeted treatment decisions. For example, in February 2024, the UK Health Security Agency reported that in week 4 of 2024, the influenza positivity rate rose to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also increased, reaching 9.8 per 100,000 people compared to 7.5 per 100,000 in the prior week, while influenza hospitalizations climbed from 5.12 to 7.63 per 100,000. Consequently, the growing incidence of infectious diseases is fueling the expansion of the acute care syndromic testing market.

Leading companies in the acute care syndromic testing market are leveraging advancements in multiplex real-time polymerase chain reaction (PCR) technology to enhance diagnostic accuracy, enable rapid pathogen detection, streamline laboratory workflows, and reduce turnaround time. Multiplex real-time PCR is an advanced molecular diagnostic method that simultaneously detects and quantifies multiple pathogens or genetic targets in a single reaction, improving efficiency and accuracy in disease diagnosis. In April 2023, QIAGEN N.V., a Netherlands-based biotechnology company, launched the QIAstat-Dx syndromic testing solution in Japan. This system features a SARS-CoV-2 respiratory panel capable of detecting over 20 pathogens from a single sample. Using multiplex real-time PCR technology, it provides rapid results with minimal labor compared to traditional PCR assays. By the end of 2022, over 3,500 QIAstat-Dx systems had been installed worldwide, aiding in the diagnosis of respiratory, gastrointestinal, and meningitis-related conditions. Available in more than 100 countries, this system is improving global access to syndromic testing.

In May 2023, Applied BioCode, a US-based biotechnology company, partnered with Medline Industries to expand the distribution of the BioCode MDx-3000 System. This collaboration aims to enhance access to diagnostic testing for hospitals and reference laboratories across the U.S. Medline Industries LP, a US-based healthcare company specializing in medical supplies and healthcare services, will support the distribution of Applied BioCode's multiplex diagnostic solutions, further advancing syndromic testing capabilities.

Major players in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., and Applied BioCode Inc.

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in acute care syndromic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute care syndromic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute care syndromic testing market consists of revenues earned by entities by providing services such as comprehensive pathogen detection, rapid turnaround time, and support for antimicrobial stewardship. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute care syndromic testing market also includes sales of blood collection tubes, or urine containers, PCR and RT-PCR machines, and reader devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Care Syndromic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute care syndromic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute care syndromic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute care syndromic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Respiratory Diseases; Gastrointestinal Diseases; Genitourinary Diseases; Tropical Diseases; Other Disease Types
  • 2) By Sample Type: Blood; Urine; Biofluids; Stool; Swabs; Other Sample Types
  • 3) By Target: Bacteria; Viruses; Fungi; Parasites
  • 4) By End User: Hospitals; Clinical And Diagnostic Laboratories; Research And Academic Institutions; Other End Users
  • Subsegments:
  • 1) By Respiratory Diseases: Influenza; Respiratory Syncytial Virus (RSV); COVID-19; Tuberculosis; Other Respiratory Diseases
  • 2) By Gastrointestinal Diseases: Clostridium Difficile Infection; Norovirus; Rotavirus; Salmonella; Other Gastrointestinal Diseases
  • 3) By Genitourinary Diseases: Urinary Tract Infections (UTIs); Sexually Transmitted Infections (STIs); Vaginal Infections; Other Genitourinary Diseases
  • 4) By Tropical Diseases: Malaria; Dengue; Chikungunya; Zika Virus; Other Tropical Diseases
  • 5) By Other Disease Types: Meningitis; Sepsis; Other Emerging Infectious Diseases
  • Companies Mentioned: Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Care Syndromic Testing Market Characteristics

3. Acute Care Syndromic Testing Market Trends And Strategies

4. Acute Care Syndromic Testing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Acute Care Syndromic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Acute Care Syndromic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Acute Care Syndromic Testing Market Growth Rate Analysis
  • 5.4. Global Acute Care Syndromic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Acute Care Syndromic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Acute Care Syndromic Testing Total Addressable Market (TAM)

6. Acute Care Syndromic Testing Market Segmentation

  • 6.1. Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Respiratory Diseases
  • Gastrointestinal Diseases
  • Genitourinary Diseases
  • Tropical Diseases
  • Other Disease Types
  • 6.2. Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Urine
  • Biofluids
  • Stool
  • Swabs
  • Other Sample Type
  • 6.3. Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacteria
  • Viruses
  • Fungi
  • Parasites
  • 6.4. Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical And Diagnostic Laboratories
  • Research And Academic Institutions
  • Other End Users
  • 6.5. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • COVID-19
  • Tuberculosis
  • Other Respiratory Diseases
  • 6.6. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clostridium Difficile Infection
  • Norovirus
  • Rotavirus
  • Salmonella
  • Other Gastrointestinal Diseases
  • 6.7. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urinary Tract Infections (UTIs)
  • Sexually Transmitted Infections (STIs)
  • Vaginal Infections
  • Other Genitourinary Diseases
  • 6.8. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Malaria
  • Dengue
  • Chikungunya
  • Zika Virus
  • Other Tropical Diseases
  • 6.9. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Meningitis
  • Sepsis
  • Other Emerging Infectious Diseases

7. Acute Care Syndromic Testing Market Regional And Country Analysis

  • 7.1. Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Care Syndromic Testing Market

  • 8.1. Asia-Pacific Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Care Syndromic Testing Market

  • 9.1. China Acute Care Syndromic Testing Market Overview
  • 9.2. China Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Care Syndromic Testing Market

  • 10.1. India Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Care Syndromic Testing Market

  • 11.1. Japan Acute Care Syndromic Testing Market Overview
  • 11.2. Japan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Care Syndromic Testing Market

  • 12.1. Australia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Care Syndromic Testing Market

  • 13.1. Indonesia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Care Syndromic Testing Market

  • 14.1. South Korea Acute Care Syndromic Testing Market Overview
  • 14.2. South Korea Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Care Syndromic Testing Market

  • 15.1. Western Europe Acute Care Syndromic Testing Market Overview
  • 15.2. Western Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Care Syndromic Testing Market

  • 16.1. UK Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Care Syndromic Testing Market

  • 17.1. Germany Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Care Syndromic Testing Market

  • 18.1. France Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Care Syndromic Testing Market

  • 19.1. Italy Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Care Syndromic Testing Market

  • 20.1. Spain Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Care Syndromic Testing Market

  • 21.1. Eastern Europe Acute Care Syndromic Testing Market Overview
  • 21.2. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Care Syndromic Testing Market

  • 22.1. Russia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Care Syndromic Testing Market

  • 23.1. North America Acute Care Syndromic Testing Market Overview
  • 23.2. North America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Care Syndromic Testing Market

  • 24.1. USA Acute Care Syndromic Testing Market Overview
  • 24.2. USA Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Care Syndromic Testing Market

  • 25.1. Canada Acute Care Syndromic Testing Market Overview
  • 25.2. Canada Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Care Syndromic Testing Market

  • 26.1. South America Acute Care Syndromic Testing Market Overview
  • 26.2. South America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Care Syndromic Testing Market

  • 27.1. Brazil Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Care Syndromic Testing Market

  • 28.1. Middle East Acute Care Syndromic Testing Market Overview
  • 28.2. Middle East Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Care Syndromic Testing Market

  • 29.1. Africa Acute Care Syndromic Testing Market Overview
  • 29.2. Africa Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Care Syndromic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Acute Care Syndromic Testing Market Competitive Landscape
  • 30.2. Acute Care Syndromic Testing Market Company Profiles
    • 30.2.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Acute Care Syndromic Testing Market Other Major And Innovative Companies

  • 31.1. Seegene Inc.
  • 31.2. bioMerieux SA
  • 31.3. Sysmex Corporation
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. QIAGEN N.V.
  • 31.6. Werfen
  • 31.7. DiaSorin S.p.A.
  • 31.8. Quidel Corporation
  • 31.9. Luminex Corporation
  • 31.10. Biocartis NV
  • 31.11. Microbiologics Inc.
  • 31.12. QuantuMDx Group Ltd.
  • 31.13. Curetis GmbH by OpGen Inc.
  • 31.14. Genetic Signatures Ltd.
  • 31.15. Applied BioCode Inc.

32. Global Acute Care Syndromic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Care Syndromic Testing Market

34. Recent Developments In The Acute Care Syndromic Testing Market

35. Acute Care Syndromic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Acute Care Syndromic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Acute Care Syndromic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Acute Care Syndromic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer